Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-199201 for Erythema in Rosacea
NCT01735201Phase 2Completed
- Sponsor
- Allergan
- Start
- Dec 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxymetazoline in rosacea, sponsored by Allergan. Started Dec 2012; status: completed.
02
Drugs
oxymetazoline
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01735201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01735201.